Clinical Trial Update: Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292) [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial of Nasonex (mometasone furoate nasal spray) for nasal polyps in children aged 6 to under 18 completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal Polyps

Drugs mentioned

• Nasonex (mometasone furoate)

Snippet

Sponsor: Organon and Co | Conditions: Nasal Polyps | Phase 3 | Status: COMPLETED | Results posted: 2010-07-20